References
- 1. Dienstag JL. Hepatitis B virus infection. N Engl J Med. 2008; 359:1486-500.10.1056/NEJMra0801644
- 2. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001; 344:495-500.10.1056/NEJM200102153440706
- 3. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003; 38:1449-57.10.1016/j.hep.2003.09.022
- 4. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003; 29:1705-13.10.1016/j.ultrasmedbio.2003.07.001
- 5. Cardoso AC, Carvalho-Filho RJ, Marcellin P. Transient elastography in chronic viral hepatitis: a critical appraisal. Gut. 2011; 60:759-64.10.1136/gut.2010.220863
- 6. Marcellin P, Ziol M, Bedossa P, Douvin C, Poupon R, de L dinghen V, et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int. 2009; 29:242-7.10.1111/j.1478-3231.2008.01802.x
- 7. Kim SU, Ahn SH, Park JY, Kang W, Kim do Y, Park YN, et al. Liver stiffness measurement in combination with noninvasive markers for the improved diagnosis of B-viral liver cirrhosis. J Clin Gastroenterol. 2009; 43: 267-71.10.1097/MCG.0b013e31816f212e
- 8. Chan HL, Wong GL, Choi PC, Chan AW, Chim AM, Yiu KK, et al. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat. 2009; 16:36-44.10.1111/j.1365-2893.2008.01037.x
- 9. Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, Colombatto P, et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat. 2007; 14: 360-9.10.1111/j.1365-2893.2006.00811.x
- 10. Martinez SM, Crespo G, Navasa M, Forns X. Noninvasive assessment of liver fibrosis. Hepatology. 2011; 53:325-35.10.1002/hep.24013
- 11. Mukherjee S, Sorrell MF. Noninvasive tests for liver fibrosis. Semin Liver Dis. 2006; 26:337-47.10.1055/s-2006-951598
- 12. McHutchison JG, Blatt LM, de Medina M, Craig JR, Conrad A, Schiff ER, et al. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. J Gastroenterol Hepatol. 2000; 15:945-51.10.1046/j.1440-1746.2000.02233.x
- 13. Guechot J, Poupon RE, Poupon R. Serum hyaluronan as a marker of liver fibrosis. J Hepatol. 1995; 22:103-6.10.1016/0168-8278(95)80255-X
- 14. Tangkijvanich P, Kongtawelert P, Pothacharoen P, Mahachai V, Suwangool P, Poovorawan Y. Serum hyaluronan: a marker of liver fibrosis in patients with chronic liver disease. Asian Pac J Allergy Immunol. 2003; 21:115-20.
- 15. Kongtawelert P, Ghosh P. A method for the quantitation of hyaluronan (hyaluronic acid) in biological fluids using a labeled avidin-biotin technique. Anal Biochem. 1990; 185:313-8.10.1016/0003-2697(90)90300-X
- 16. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996; 24: 289-93.10.1002/hep.510240201
- 17. Ganne-Carri N, Ziol M, de Ledinghen V, Douvin C, Marcellin P, Castera L, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology. 2006; 44:1511-7.10.1002/hep.21420
- 18. Wang JH, Changchien CS, Hung CH, Eng HL, Tung WC, Kee KM, et al. FibroScan and ultrasonography in the prediction of hepatic fibrosis in patients with chronic viral hepatitis. J Gastroenterol. 2009; 44: 439-46.10.1007/s00535-009-0017-y
- 19. Cho HJ, Seo YS, Lee KG, Hyun JJ, An H, Keum B, et al. Serum aminotransferase levels instead of etiology affects the accuracy of transient elastography in chronic viral hepatitis patients. J Gastroenterol Hepatol. 2011; 26:492-500.10.1111/j.1440-1746.2010.06419.x
- 20. Cast_ra L, Bernard PH, Le Bail B, Foucher J, Trimoulet P, Merrouche W, et al. Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers. Aliment Pharmacol Ther. 2011; 33:455-65.10.1111/j.1365-2036.2010.04547.x
- 21. Malik R, Lai M, Sadiq A, Farnan R, Mehta S, Nasser I, et al. Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis. J Gastroenterol Hepatol. 2010; 25:1562-8.10.1111/j.1440-1746.2010.06371.x
- 22. Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, et al. Performance of transient elastography for the staging of liver fibrosis: a metaanalysis. Gastroenterology. 2008; 134:960-74.10.1053/j.gastro.2008.01.034
- 23. Arena U, Vizzutti F, Corti G, Ambu S, Stasi C, Bresci S, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology. 2008; 47:380-4.10.1002/hep.22007
- 24. Sagir A, Erhardt A, Schmitt M, Haussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology. 2008; 47: 592-5.10.1002/hep.22056
- 25. Wong GL, Wong VW, Choi PC, Chan AW, Chim AM, Yiu KK, et al. Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B. J Gastroenterol Hepatol. 2009; 24:1002-7.10.1111/j.1440-1746.2009.05779.x
- 26. Fung J, Lai CL, Fong DY, Yuen JC, Wong DK, Yuen MF. Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis. Liver Int. 2008; 28:1408-16.10.1111/j.1478-3231.2008.01784.x
- 27. Fung J, Lai CL, Chan SC, But D, Seto WK, Cheng C, et al. Correlation of liver stiffness and histological features in healthy persons and in patients with occult hepatitis B, chronic active hepatitis B, or hepatitis B cirrhosis. Am J Gastroenterol. 2010; 105:1116-22.10.1038/ajg.2009.665
- 28. Kim SU, Seo YS, Cheong JY, Kim MY, Kim JK, Um SH, et al. Factors that affect the diagnostic accuracy of liver fibrosis measurement by Fibroscan in patients with chronic hepatitis B. Aliment Pharmacol Ther. 2010; 32: 498-505.10.1111/j.1365-2036.2010.04353.x
- 29. Stibbe KJ, Verveer C, Francke J, Hansen BE, Zondervan PE, Kuipers EJ, et al. Comparison of noninvasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients. Scand J Gastroenterol. 2011; 46:962-72.10.3109/00365521.2011.574725
- 30. Zhu X, Wang LC, Chen EQ, Chen XB, Chen LY, Liu L, et al. Prospective evaluation of FibroScan for the diagnosis of hepatic fibrosis compared with liver biopsy/AST platelet ratio index and FIB-4 in patients with chronic HBV infection. Dig Dis Sci. 2011; 56: 2742-9.10.1007/s10620-011-1659-1
- 31. Anastasiou J, Alisa A, Virtue S, Portmann B, Murray- Lyon I, Williams R. Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy. Eur J Gastroenterol Hepatol. 2010; 22:474-80.10.1097/MEG.0b013e328332dd0a
- 32. Wong GL, Wong VW, Choi PC, Chan AW, Chan HL. Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B. Aliment Pharmacol Ther. 2010; 31:1095-103.10.1111/j.1365-2036.2010.04276.x
- 33. Halfon P, Bourliere M, Penaranda G, Deydier R, Renou C, Botta-Fridlund, et al. Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comp Hepatol. 2005; 4:6. doi:10.1186/1476-5926-4-6.